Filing Details

Accession Number:
0001209191-21-042812
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-23 17:55:34
Reporting Period:
2021-06-19
Accepted Time:
2021-06-23 17:55:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1515673 Ultragenyx Pharmaceutical Inc. RARE Pharmaceutical Preparations (2834) 272546083
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1780113 Erik Harris 60 Leveroni Court
Novato CA 94949
Evp & Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-06-19 437 $94.63 26,280 No 4 S Direct
Common Stock Disposition 2021-06-21 572 $94.96 25,708 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
  2. The sales reported on the transaction date of June 21, 2021 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  3. Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.